Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
Jamrozik, E; Littler, K; Bull, S; Emerson, C; Kang, G; Kapulu, M; Rey, E; Saenz, C; Shah, S; Smith, PG
; +4 more...Upshur, R; Weijer, C; Selgelid, MJ; WHO Working Group for Guidance on Human Challenge Studies in COV and
(2020)
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
Vaccine, 39 (4).
pp. 633-640.
ISSN 0264-410X
DOI: 10.1016/j.vaccine.2020.10.075
; +4 more...Upshur, R; Weijer, C; Selgelid, MJ; WHO Working Group for Guidance on Human Challenge Studies in COV and
(2020)
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
Vaccine, 39 (4).
pp. 633-640.
ISSN 0264-410X
DOI: 10.1016/j.vaccine.2020.10.075
This report of the WHO Working Group for Guidance on Human Challenge Studies in COVID-19 outlines ethical standards for COVID-19 challenge studies. It includes eight Key Criteria related to scientific justification, risk-benefit assessment, consultation and engagement, co-ordination of research, site selection, participant selection, expert review, and informed consent. The document aims to provide comprehensive guidance to scientists, research ethics committees, funders, policymakers, and regulators in deliberations regarding SARS-CoV-2 challenge studies by outlining criteria that would need to be satisfied in order for such studies to be ethically acceptable.
-
description - WHO Ethics Key Criteria_Vaccine_10Oct2020 ps.docx
-
subject - Submitted Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
Downloads